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Background: Polycystic ovary syndrome (PCOS) is a complex reproductive endocrinopathy affecting up to 20% of
reproductive aged women. Whilst there are effective pharmaceutical treatment options, women with PCOS have
expressed a strong desire for alternatives. This study investigates the use and attitudes of women with PCOS
towards complementary medicine (CM).
Methods: Women as members of PCOS support groups responded to an anonymous on-line survey which examined
rates and patterns of use for CM’s, areas of health for use, perceptions of effectiveness, safety and demographic features.
Data collection targeted women with PCOS using two consumer support groups. The first group self-selected following
direct email to members of a land based consumer support group, the Polycystic Ovary Syndrome Association of
Australia (POSAA). The second sample was generated through the electronic social network Facebook, using a snowball
technique. Two surveys, identical in content, were collected by cloud based Survey Monkey. Data were described and
associations between the variables, ‘reasons for use’ and ‘perceptions of effectiveness’ were explored. Non-response bias
was assessed using a continuum of resistance model.
Results: 493 women participated in the study; 91.1% response rate from the POSAA group. Over 70% reported use of
complementary medicine, usually nutritional and herbal supplements and 76.6% of CM users reported consultation
with a complementary practitioner. Many participants were using CM to treat PCOS however most were using it to
concurrently treat a range of health conditions, describing women’s desire for more than single symptom
management. Disadvantages for CM use were cited by 71% of respondents. Women using complementary medicine
with specific treatment goals in mind reported greater self-perceived effectiveness, suggesting that informed use may
improve women’s satisfaction with CM. Adverse reactions were reported by 12.2% of women and the need for further
research into adverse reactions for CM’s was identified. Demographic and PCOS characteristics were similar to clinical
populations of PCOS and non-response bias was shown as not significant.
Conclusion: This study describes the prevalence of use for complementary medicine by women with PCOS as over
70% and adds to our understanding of women’s experiences with CM and their motivations for use of CM.Background
Polycystic ovary syndrome (PCOS) is a complex endo-
crine disorder affecting up to one in five reproductive
aged women [1]. PCOS is a life-long condition associ-
ated with significant endocrine, reproductive and psy-
chological morbidity and serious long term health risks
[2-4]. The exact cause is unknown however it is believed* Correspondence: s.arentz@uws.edu.au
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in utero environment and lifestyle behaviors [4]. Current
treatments are only moderately effective at controlling
symptoms and preventing complications [2] and women
with PCOS have expressed strong dissatisfaction towards
pharmaceutical therapies. In a survey of women with
PCOS (n = 657), 99% indicated they would prefer to use
effective and safe alternative treatments to birth control
pills and fertility drugs for the management of their
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coincide with the increasing prevalence for complemen-
tary medicine (CM) use. In a critical review of 14 stud-
ies, the prevalence of CM use by pregnant women was
shown to range up to 87% [6]. Other studies have dem-
onstrated similar rates of CM use by women attending
family planning clinics [7] and by menopausal women [8].
The landmark Australian Women’s Health longitudinal
study of 11,454 women highlighted that nearly one third
of middle aged women had consulted a complementary
practitioner (chiropractor, naturopath, acupuncturist or
herbalist) within the previous twelve months [9].
To date there have been no investigations into the use
of CM by women with PCOS. This study aimed to
examine the prevalence of use, the views and patterns of
CM use including women’s attitudes, views of CM ef-
fectiveness and self-reported adverse events from CM.
Method
Study participants completed an on-line, web-based ques-
tionnaire which examined demographic features, patterns
of complementary medicine (CM) use, use of CM relating
to symptoms of PCOS, perceptions of effectiveness and
safety, sources of information on CM and concurrent use
of CM with western medicine.
Women with PCOS were recruited through two ap-
proaches; (i) convenience sampling of women belonging to
the support/advocacy group Polycystic Ovary Syndrome
Association of Australia (POSAA) and (ii) a snowballing
technique and response to an invitation posted on the so-
cial network site Facebook with a link to the ‘University Re-
search for PCOS’ Facebook group. Self-referrals were
received from the following Facebook groups based in two
metropolitan areas in Sydney and New South Wales; PCOS
Cysters (121 members); PCOS TTC (333 members); and
PCOS Talk (2011 members). This study was approved by
the Human Research Ethics Committee at the University of
Western Sydney (EC00314) reference H9341.
The research instrument
We defined CM from an adaptation of the Cochrane
Collaboration operational definition [10]. Specifically,
our definition for CM was ‘alternative or natural therap-
ies or medicines including taking dietary supplements
(herbal, vitamins, minerals and/or food supplements, for
example fish oils or barley greens) and or consulting
traditional, alternative and complementary practitioners’.
Participants were informed about specific types of CMs
at the beginning of relevant questions with an extensive
list of options and an open question for ‘others’ at the end.
Two prevalence questions included the option ‘prescribed
by a doctor’ to identify mainstream use rather than com-
plementary medicine use. A six point Likert scale ranging
from ‘daily’ to ‘as required’ enabled participants to reporttheir frequency of use. Participants were asked their reasons
for using complementary medicine and could indicate their
response to fourteen symptom options. Responses were not
limited to one option. Questions about signs and symptoms
of PCOS and current management preceded CM use and
demographic characteristics. (Additional file 1. The survey
instrument.) The research tool was tested on a pilot sample
of eight women including four with PCOS.
Survey administration
The questionnaire was administered using Survey Monkey
[11]. An email containing a letter of invitation and an elec-
tronic link to the questionnaire was sent to all members of
POSAA in November 2011. Two reminders were sent out
at six-week intervals. The second approach used to dis-
tribute the questionnaire to the community utilized a
Facebook group created by the researcher (SA) in February
2012. Facebook groups are virtual communities of choice,
linking people with shared interests, attributes or causes.
Wall postings occurred bi-monthly during the study
administration.
Data analyses
Analysis was undertaken using the statistical package,
SPSS version 21.0 [12]. Categorical responses were re-
ported as numbers and percentages with 95% confi-
dence intervals. Relationships between variables were
explored using Pearson’s correlation (two tail) for nor-
mally distributed data (use of CM) and Spearman’s Rho
correlations or Gamma co-efficient for non-parametric
measurements (type of CM practitioner). Logistic re-
gression was used to predict whether or not perceptions
of effectiveness (dependent variables) were associated
with reasons for use (covariates). A value of 0.05 was
considered statistically significant with 95% confidence
intervals.
Non-response bias was assessed using the continuum of
resistance model; this involves late responders viewed by
proxy as non-responders due to similar characteristics
[13]. This method of assessment was chosen due to the
higher likelihood for early response by women who found
the topic salient or interesting [14]. Responses to the sur-
vey four months after the final reminder were classified as
late responders and compared for difference with early re-
sponses to assess the impact of non-response bias.
Results
Response rate
Four hundred and ninety three (493) women with PCOS
responded to the survey. A response was received from
235 invited members of the consumer support group
POSAA (response rate of 91.1%). An additional 311
women who responded to the survey used the University
Research Facebook group.
Table 1 Demographic characteristics of respondents
N = 493 % 95% CI
Age
17 or less 3 0.7 ± 0.79
18-24 72 17.0 ± 3.58
25-29 126 29.7 ± 4.35
30-34 111 26.2 ± 4.19
35-40 71 16.7 ± 3.55
41-44 25 5.9 ± 2.24




Yes 371 87.5 ± 3.15
Missing data 69
Completed tertiary education
Yes 323 76.2 ± 4.05
Missing data 69
Qualification from TAFE 103 20.9 ± 3.59
Private institution Diploma 70 14.2 ± 3.08
University degree 221 44.8 ± 4.39
Missing data 99
Ethnicity- country of birth
Australia 302 61.3 ± 4.3
Other 121 24.5 ± 2.08
Missing data 70
Employment
Home duties 117 23.7 ± 3.75
Self-employed 38 7.7 ± 2.35
Student 80 16.2 ± 3.25
Employed part time 103 20.9 ± 3.59
Employed full-time 194 39.4 ± 4.31
Other 12 2.4 ± 1.35
Missing data 68
Private Health Insurance
Yes 275 65 ± 4.55
Missing data 70
Missing data for age, complete high school, tertiary education, ethnicity,
employment and health insurance was 14.0%. Missing data for qualifications 20.1%.
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and 34 years, born in Australia, attained tertiary qualifi-
cations, were employed and held private health insur-
ance (Table 1).
Women reported multiple symptoms of PCOS. The most
common included late menses (69%, ±4.31, 95% CI); hirsut-
ism (66%, ±4.20, 95% CI); acne (51%,±4.52, 95% CI); insulin
imbalances ( 56%, ±4.63, 95% CI), being overweight (78%,
±4.46, 95% CI) or very overweight, (51%, ±4.61, 95% CI).
Other health complaints included depression (45%, ±4.64,
95% CI) and infertility (53%, ±4.49, 95% CI).
The respondents used various medical therapies to
manage their symptoms. Over 65% (±4.21, 95% CI) had
used the oral contraceptive pill; 62.7% (±4.26, 95% CI)
had used other pharmaceuticals including ovulation in-
duction, hypoglycaemic and anti-androgen drugs. Medi-
cations used to stimulate the ovaries for IVF were
reported by 11.8% (±2.87, 95% CI).
Use of complementary medicines and therapies
Three hundred and four, out of 432 women (70.4%
±4.30 95% CI) reported using complementary medicine
(CM) in the previous 12 months.
Women were asked about their intake habits (Table 2).
The most commonly used CM products taken on a daily
basis were dietary supplements including vitamins, min-
erals and food nutrients such as fish oil capsules, and
herbal supplements. Two hundred and seven of 432 re-
spondents (47.9% ±4.71 95% CI) reported use of more
than one type of CM product.
Complementary practitioner visits
Consultations with acupuncturists, chiropractors, natu-
ropaths, and massage therapists in the previous twelve
months were reported by 233 of 304 CM users (76.6% ±
4.76 95% CI) (Table 3) . A smaller number of women
also consulted medical doctors for acupuncture treatment
or integrative medicine which was provided within the
general medical setting. Nearly half of respondents using
CM consulted multiple CM practitioners during the previ-
ous twelve months, usually an acupuncturist and naturo-
path (n = 47, 15.5% ±4.07 95% CI) or an acupuncturist and
chiropractor (n = 41, 13.5% ±3.84 95% CI).
Reasons for using Complementary Medicine (CM)
Many women were using CM to treat PCOS (n = 199,
65.5%, ± 5.34, 95% CI) however the majority of partici-
pants reported using CM to assist with improving more
than one aspect of their health (n = 277, 76.7%, ± 4.75,
95% CI). The most common reasons for use were to im-
prove general wellbeing (n = 135, 44.4% ± 5.59 95% CI);
and to treat PCOS symptoms and infertility (n = 102,
33.6%, ± 5.31, 95% CI), and treat PCOS and reduce de-
pression (n = 92, 30.3% ± 5.17 95% CI).Views about CM
Twenty seven percent of CM users (n = 82, ± 5.99, 95% CI)
indicated they thought CM used alone was effective man-
agement for PCOS and 24.7% (n = 75, ±4.85, 95% CI) re-
ported that CM was effective for PCOS in conjunction with
diet and exercise. Participant’s indicated they thought
CM was effective for treating more than one condition,
Table 2 Types of ingestible complementary medicine taken by participants and frequency of use
Complementary medicine use N = 432 Daily use Weekly use Total use 95% CI
N % N % N %
Nutritional supplements, including vitamins, minerals, nutrients from food such as fish oil. 192 44.4 92 21.3 246 56.9 ± 4.67
Herbal medicines including herbal tea (for therapeutic reasons), tablets and liquids. 138 31.94 55 12.73 181 41.9 ± 4.65
Vitamins and/or minerals prescribed by a medical doctor 62 14.4 10 2.3 63 14.6 ± 3.33
Multiple forms of CAM products 137 31.71 70 16.2 207 47.9 ± 4.71
Total use 238 55.1 179 41.4 304 70.4 ± 4.3
● Categories were not mutually exclusive, women may have been using more than one product/modality with variable patterns of use.
● CI confidence interval.
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general well-being (n = 96, 31.6%,± 5.23 95% CI), sleep
( n = 51, 16.8%,±4.22 95% CI) and weight loss (n = 48,
15.8%,± 4.09 95% CI). A smaller number of women
considered CM was effective for infertility (n = 33,
10.9% ± 3.5 95% CI).
Significant relationships were found between using
CM to treat specific conditions and perceptions of effect-
iveness. Use of CM to treat PCOS (n = 199), was associated
with effectiveness of CM by 40.8% (PCC 4.64, p = 0.001)
of participants. Use of CM as treatment for infertility
(n = 102) was associated with effectiveness by 32.4% (PCC
3.84, p = 0.001) of women and the treatment goal, ‘to
improve wellbeing’ (n = 134), was associated with 71.6%
(PCC 4.04, p = 0.001) of women reporting effectiveness.
Predictions were found for using CM to treat PCOS
and perceptions of effectiveness for PCOS (odds ratio
(OR) 24.8, CI 11.1-55.3, p = 0.0001); infertility, (OR 18.8,
CI 7.9-44.8, p = 0.0001) and for improved wellbeing (OR
8.8, CI 5.2-14.9, p = 0.0001).Table 3 Consultations with a complementary practitioner
during the previous twelve months
Use of CM N % 95% CI
N = 304
Consultations with CM practitioners 233 76.6 ± 4.76
More than one type of CM practitioner 136 44.7 ± 5.59
Naturopath 118 38.8 ± 5.48
Chiropractor 103 33.9 ± 5.32
Acupuncturist 88 28.9 ± 5.1
Massage therapist 79 25.1 ± 4.87
Osteopath 41 13.5 ± 3.84
Reflexologist, aromatherapist, iridologist 36 11.8 ± 3.63
Homoeopath 34 11.2 ± 3.55
Medical doctor for integrative medicine 27 8.9 ± 3.2
Kinesiologist 20 6.6 ± 2.79
Medical doctor for acupuncture 14 4.6 ± 2.35
• Footnote: 301 women responded to this question, missing data = 3.
• Responses were not limited to single options with 136 providing more than
one response for type of CM practitioner.
• CI, confidence interval.Advantages for CM were reported by 52.5% (n = 259, ±
4.41, 95% CI). These included perceived naturalness of
CM (n = 157, 60.6% ± 5.95, 95% CI), the complementary
nature of treatment (n = 120, 46.3% ± 6.07, 95% CI), per-
ceived low risk of side effects (n = 104, 40.2%, ± 5.97, 95%
CI), increased self- responsibility (n = 81, 31.3%, ± 5.65,
95% CI) and the holistic nature of CM (n = 75, 29%, ± 5.52
95% CI).
Disadvantages associated with CM use were cited by
354 women (71.8%, ± 3.97 95% CI). These included CM
being too expensive (n = 187, 52.8% ± 5.2, 95% CI), lack
of research into CM (n = 175, 49.4% ± 5.21 95% CI) and
163 women (46.0% ± 5.19, 95%CI) were not confident
about a benefit from CM. A small number of women
(13.6%, ± 3.57, 95% CI) indicated they were not confident
to use CM in conjunction with other pharmaceuticals.
Adverse reactions and CM
Participants were asked about any adverse reactions or
negative experiences with their use of CM. Adverse reac-
tions to nutritional and herbal supplements, Traditional
Chinese Herbal Medicine (TCHM) and acupuncture were
reported by thirty seven CM users (12.2%, ±3.68, 95% CI).
Nine reactions were to vitamins, seven to fish oil supple-
ments, six to TCM including two to acupuncture, two to
herbal teas and five to vitamin supplements prescribed by
a medical practitioner. Eleven adverse reactions were re-
ported including longer menstrual cycles, changes to
bowel habits, sleep disturbances and headaches.
Assessment for non-response bias and selection bias
When testing for non-response bias for early and late re-
sponders no significant differences were noted in the demo-
graphic characteristics, symptoms of PCOS and prevalence
for use of CM between any of the surveyed groups.
Discussion
The use of complementary medicine by women has in-
creased in recent years. We present the first survey of
women with PCOS and report high use of CM, with nearly
three out of four women reporting use and nearly half
reporting use of multiple CM’s. This study demonstrates
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associated with PCOS when using CM’s and that well-
being, reproductive and mental health are important as-
pects of care. Our findings are limited by the sampling
framework and the referral of participants through support
groups, since women with PCOS whom have not sought
support through POSAA or electronic social media, or
women with PCOS in the community who have not been
diagnosed [1] were not represented in this study.
We found women have similar preferences for the
types of CM use to those reported in reproductive health
settings where nutritional and herbal supplements were
the most commonly reported CM (comparatively, 56%
for women attending family planning clinics and 78% of
women attending fertility clinics) [7,15]. However, our
findings differ to studies showing recently increased
preferences for acupuncture compared to naturopaths
[7,16]. These differences may be explained by our study
focusing only on women with PCOS, the definition of
CM modalities used or influenced by recent statutory
registration of acupuncture practitioners in Australia.
Most women perceived the effectiveness of CM as at
least somewhat helpful. This aligns with findings from
other surveys of women attending family planning clinics
[7], pregnant women [17] and middle aged women [8].
Our data show women’s perceptions of effectiveness were
increased when they used CM with specific treatment
goals in mind. Little is known about how women with
PCOS acquire information and make decisions regarding
suitable CM’s. This extended beyond the scope of our
study however our findings demonstrate the value of in-
formed CM treatment decisions and highlight the decision
process for CM as an area of future research need. The
main disadvantage for CM cited in this study was the lack
of research which reiterates women’s need for unbiased in-
formation to support their CM decisions.
Our data corresponds with findings reporting women
have reduced recognition for potential hazards for CM
[7,18,19]. Some herbal medicines taken in conjunction
with pharmaceuticals may have adverse effects. Hypericum
perforatum (St Johns wort) for example, has been shown
to reduce pharmaceutical effectiveness [20-22]. Import-
antly, our findings report participant’s high use for herbal
medicines and high use of pharmaceuticals including the
oral contraceptive pill (over 65%). Future research is
needed to examine concurrent use of pharmaceuticals and
CM by women with PCOS, and the rate of adverse events
attributable to reduced pharmaceutical effectiveness.
The rate of adverse events reported here was not as
low as in other studies. A survey of TCM (Chinese
herbal medicine and acupuncture) practitioners dem-
onstrated adverse reaction rates of one per 633 con-
sultations [23]. Comparatively there were six adverse
reactions for TCM out of 304 CM users. Our datainclude self-reported adverse reactions by self-
prescribing consumers with potentially poorly in-
formed treatment choices. This may explain the higher
rates of adverse reactions in this case. On the other
hand, adverse reactions reported by TCM practitioners
may be at risk of reporting bias. Our research high-
lights that women with PCOS do experience adverse
reactions when using CM, despite perceptions of low
risk.
This study does have some methodological limitations.
We were unable to directly assess non-response and se-
lection bias for the Facebook group. The referral to the
survey by administrators of other Facebook support
groups limited our ability to gauge unsolicited invita-
tions and data were not available for assessment using
the continuum of resistance model. Generalizations are
limited to computer literate women with English lan-
guage skills and other groups of women may be under-
represented. However the results may be generalisable
to women with PCOS. Women reported similar preva-
lence for key PCOS signs and symptoms to clinical pop-
ulations for hirsutism (55.6% [1], 66% [24] and 75% [25])
and menstrual irregularities (62.5% [1], 66% [24] and
89% [25]). This suggests that the respondents resemble a
clinical population with PCOS. We also attained a good
response rate without response bias from women with
PCOS in a non-clinical setting, not restricted by geo-
graphical location. This survey had high completion
rates and suggests that the methods were acceptable to
women. For these reasons our data are likely to reflect
the authentic views of women with PCOS in the com-
munity. This research was focused on the use of CM by
women with PCOS and differentiates CM from other
lifestyle practices; however women often use CM within
the context of other lifestyle behaviors, including diet
and exercise. The prevalence, patterns and attitudes to-
wards diet and exercise of women with PCOS was be-
yond the scope of the present article.
Conclusion
Complementary medicine may present a treatment op-
tion with high acceptance by women; this study is an
important step in developing our understanding of this
group of women’s views and patterns of CM use.Additional file
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